Biotech Values

[DewDiligence]

>>It is the fields they cover. That is their interest. It's not "pumping".<<

Dan, this has been discussed on this board ad nauseam but, what the heck, I’ll do it one more time.

In my opinion, it’s all but impossible for a long-only newsletter writer with a small selection universe to be objective. What does such a writer do if there are no attractive stocks in the small selection universe at a given time? Tell subscribers that there is nothing interesting to buy? Advise subscribers to put their money into money-market funds?

From a practical standpoint, this can’t be done because many subscribers will simply stop subscribing. Hence, there is always a rather substantial degree of “pump” in what people like BTM’s Miller and Neuro write in their newsletters.

If you get value from these publications, that’s great. But it’s foolhardy, IMHO, to dismiss the inherent bias of their business model.

Over and out.